Human antibodies cloned by scientists at the Lankenau Institute for Medical Research (LIMR) have been adopted by the World Health Organization (WHO) as a crucial part of its plan to eradicate polio permanently.
Announced on December 9, 2022, the WHO Expert Committee on Biological Standardization approved the antibodies created in the lab of LIMR faculty member Scott Dessain, MD, Ph.D., as the standard for quality-control testing of all inactivated polio vaccines (IPV) in October 2022.
Polio Vaccine Quality Control Ensured with New Antibody Test
Will This Coronavirus Follow Soccer Home
As the FIFA World Cup 2022 in Qatar comes to a close, various countries are concerned about a seldom discussed human coronavirus (hCoV) infecting event attendees and causing disease outbreaks back home.
According to The Sun reporting on December 11, 2022, the UK Health Security Agency (UKHSA) has urged clinicians to look out for people suffering from a fever and breathing difficulties.
$30 Million Supports Developing Vaccines in Africa
A global multinational specialty pharmaceutical company announced today that it would receive USD30 million from the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations (CEPI) to support its capabilities to manufacture vaccines for Africa.
This is important news since 99% of all vaccines administered in Africa are currently imported.
Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
U.S. Health Officials Urge Indoor Masking in Major Cities as ‘Tripledemic’ Rages
During the past few weeks, COVID-19, the flu, and respiratory syncytial virus have made millions of Americans ill
Preprint, Peer-Reviewed Pairs of Studies Generally Concordant
Sample sizes, primary end points, interpretations mainly concordant for studies published on medRxiv, then in journals